Melampsora spondylitis presenting with unexplained low back pain: A case report

Weijian Zhu1, Sirui Zhou2, Zhihao Xu3

  • 1Department of Orthopedics, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.

Abstract

Insights

Fungal spondylitis, a rare spinal infection, is increasingly reported. Early diagnosis and advanced treatments are crucial for managing this condition, especially in non-immunocompromised individuals.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Spinal Surgery

Background:

  • Spondylitis, a spinal infection, is rising globally, with fungal causes being rare but serious.
  • Fungal spondylitis is often linked to immunosuppression and diabetes, but can occur in immunocompetent individuals.
  • Delayed diagnosis of fungal spondylitis can lead to severe neurological deficits and disability.

Observation:

  • A case of suspected fungal spondylitis at the L3-S1 spinal level is presented.
  • Next-generation sequencing (NGS) confirmed the diagnosis of Melampsora spondylitis.
  • The patient underwent surgical debridement with internal fixation and received antifungal and antibiotic treatment.

Findings:

  • Successful treatment of Melampsora spondylitis was achieved with voriconazole, vancomycin, and meropenem.
  • This case highlights the importance of considering fungal pathogens beyond Candida albicans in spondylitis.
  • The diagnosis of fungal spondylitis was confirmed via NGS analysis of surgical specimens.

Implications:

  • Physicians should include fungal spondylitis in the differential diagnosis for spinal infections, even in immunocompetent patients.
  • Advanced diagnostic tools like NGS are vital for identifying rare fungal pathogens causing spondylitis.
  • Developing novel therapeutic strategies is essential for improving outcomes in fungal spondylitis.